phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

Contracts with pharmacies in far-flung locations nationwide. Charity care rates abysmally low. Lack of evidence profits are used to help lower costs for patients. These are just a few of the ways you can describe many of the behaviors of 340B hospitals and their contract pharmacies.

There are nearly 3,000 340B hospitals contracting with more than 33,000 pharmacies around the country today. So, how do 340B hospitals and their contract pharmacies in your state stack up when looking at metrics related to charity care and whether contract pharmacies are targeting underserved areas? Click the map below to find out.

selected teaser image

The 340B Drug Pricing Program was designed to help vulnerable patients access medications they might not be able to afford. Unfortunately, the 340B program is broken. Today, it has become less about patients and more about boosting the bottom lines of large hospitals and for-profit pharmacies, which are mostly owned by middlemen like pharmacy benefit managers.

Comprehensive reform at the federal level is needed. Congress, not states, should put an end to the abuse of this important safety-net program and put it back on track for the patients it was meant to assist.

Gabby Migliara

Gabby Migliara is a director of Public Affairs at PhRMA focusing on internal communications and PhRMA’s digital presence, including maintaining this website and executive social presence. She previously worked with the U.S. Census Bureau on marketing and communications for the 2020 Census campaign. Outside the office, Gabby enjoys trying new restaurants, hanging with her cat and exploring D.C. neighborhoods.

As football season kicks off, hospitals keep scoring on 340B

September 9, 2026

ICYMI: Hospital consolidation is driving up health care costs

August 27, 2026

It's time to modernize 340B: The case for a rebate model

August 19, 2026

ICYMI: Fox business hosts call 340B a ‘Rotten System’ and ‘Cash Cow’ for hospitals

July 23, 2026

What’s the 340B program like in your state?

340B

What’s the 340B program like in your state?

February 7, 2024

What’s the 340B program like in your state?

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list